amiodarone has been researched along with Arrhythmogenic Right Ventricular Cardiomyopathy in 19 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years." | 7.71 | Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy. ( Hosaka, F; Kasanuki, H; Matsuda, N; Sakomura, Y; Shiga, T; Wakaumi, M, 2002) |
| "The potential severity of amiodarone-induced hyperthyroidism, particularly in severe cardiopathy cases, necessitates a regular clinic and biologic thyroid control." | 7.71 | [Value of total thyroidectomy in amiodarone-induced hyperthyroidism]. ( Carlioz, R; Chollet, O; Dariel, MP; Gouteyron, JF; Hervé, S; Leyral, H; Perrier, E, 2001) |
| "Since amiodarone was first marketed in 1992 in Japan, the incidence of amiodarone-induced thyrotoxicosis (AIT) has been increasing." | 7.70 | Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. ( Demura, H; Kanaji, Y; Kasanuki, H; Ohnishi, S; Sato, K; Yamazaki, K, 1998) |
| "The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years." | 3.71 | Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy. ( Hosaka, F; Kasanuki, H; Matsuda, N; Sakomura, Y; Shiga, T; Wakaumi, M, 2002) |
| "The potential severity of amiodarone-induced hyperthyroidism, particularly in severe cardiopathy cases, necessitates a regular clinic and biologic thyroid control." | 3.71 | [Value of total thyroidectomy in amiodarone-induced hyperthyroidism]. ( Carlioz, R; Chollet, O; Dariel, MP; Gouteyron, JF; Hervé, S; Leyral, H; Perrier, E, 2001) |
| "Since amiodarone was first marketed in 1992 in Japan, the incidence of amiodarone-induced thyrotoxicosis (AIT) has been increasing." | 3.70 | Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. ( Demura, H; Kanaji, Y; Kasanuki, H; Ohnishi, S; Sato, K; Yamazaki, K, 1998) |
| "Arrhythmogenic right ventricular cardiomyopathy is a genetic cardiomyopathy characterized by replacement of right ventricular myocardium by fibrofatty infiltrates, leading to significant ventricular arrhythmias with sudden death and right ventricular dysfunction." | 2.50 | [Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy]. ( Kato, Y, 2014) |
| "The ECG documented ventricular tachycardia (VT) when the patient has palpitations." | 1.38 | The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy. ( Bao, H; Cheng, X; Hong, K; Li, J, 2012) |
| "Arrhythmogenic right ventricular cardiomyopathy is a desmosomal disease." | 1.37 | Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. ( Smith, W, 2011) |
| "Sotalol was associated with a greater risk of any clinically relevant ventricular arrhythmia as defined by sustained ventricular tachycardia or ICD therapy (hazard ratio [HR]: 2." | 1.35 | Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. ( Cannom, DS; Estes, NA; Glidden, DV; Marcus, F; Marcus, GM; Polonsky, B; Scheinman, MM; Smith, LM; Zareba, W, 2009) |
| "We report a case of arrhythmogenic right ventricular cardiomyopathy with a right ventricular thrombus located inside a single apical aneurysm in the presence of normal right ventricular systolic function." | 1.31 | [Right ventricular thrombosis in arrhythmogenic cardiomyopathy. A case report]. ( Antonini-Canterin, F; Nicolosi, GL; Pavan, D; Sandrini, R; Zardo, F, 2000) |
| "Arrhythmogenic right ventricular dysplasia is an inherited, progressive condition." | 1.31 | Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition. ( Fisher, NG; Gilbert, TJ, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes, AC | 1 |
| Lopes, LR | 1 |
| Cruz, I | 1 |
| Almeida, AR | 1 |
| Miranda, R | 1 |
| Almeida, S | 1 |
| Brandão, L | 1 |
| Pereira, H | 1 |
| Adachi, Y | 1 |
| Hayashi, T | 1 |
| Mitsuhashi, T | 1 |
| Sakakura, K | 1 |
| Yamada, Y | 1 |
| Wada, Y | 1 |
| Horie, M | 1 |
| Momomura, SI | 1 |
| Fujita, H | 1 |
| Kato, Y | 1 |
| Bruña, V | 1 |
| Díez-Villanueva, P | 1 |
| Martínez-Sellés, M | 1 |
| Datino, T | 1 |
| Fernández-Avilés, F | 1 |
| Marcus, GM | 1 |
| Glidden, DV | 1 |
| Polonsky, B | 1 |
| Zareba, W | 1 |
| Smith, LM | 1 |
| Cannom, DS | 1 |
| Estes, NA | 1 |
| Marcus, F | 1 |
| Scheinman, MM | 1 |
| Mitchell, LB | 1 |
| Pinamonti, B | 1 |
| Dragos, AM | 1 |
| Pyxaras, SA | 1 |
| Merlo, M | 1 |
| Pivetta, A | 1 |
| Barbati, G | 1 |
| Di Lenarda, A | 1 |
| Morgera, T | 1 |
| Mestroni, L | 1 |
| Sinagra, G | 1 |
| Smith, W | 1 |
| Bao, H | 1 |
| Hong, K | 1 |
| Li, J | 1 |
| Cheng, X | 1 |
| Hosaka, F | 1 |
| Shiga, T | 1 |
| Sakomura, Y | 1 |
| Wakaumi, M | 1 |
| Matsuda, N | 1 |
| Kasanuki, H | 2 |
| Khalil, SI | 1 |
| Kamal, A | 1 |
| Ahmad, S | 1 |
| Riera, M | 1 |
| Herrero, J | 1 |
| Antón, E | 1 |
| Fiol, M | 1 |
| García-Quintana, A | 1 |
| Ortega-Trujillo, JR | 1 |
| Medina Fernández-Aceytuno, A | 1 |
| Markiewicz-Łoskot, G | 1 |
| Moric-Janiszewska, E | 1 |
| Loskot, M | 1 |
| Szydłowski, L | 1 |
| Hollek, A | 1 |
| Weglarz, L | 1 |
| van Daele, ME | 1 |
| Berger, RM | 1 |
| Smeets, J | 1 |
| Hess, J | 1 |
| Sato, K | 1 |
| Yamazaki, K | 1 |
| Kanaji, Y | 1 |
| Ohnishi, S | 1 |
| Demura, H | 1 |
| Antonini-Canterin, F | 1 |
| Sandrini, R | 1 |
| Pavan, D | 1 |
| Zardo, F | 1 |
| Nicolosi, GL | 1 |
| Fisher, NG | 1 |
| Gilbert, TJ | 1 |
| Dariel, MP | 1 |
| Hervé, S | 1 |
| Chollet, O | 1 |
| Leyral, H | 1 |
| Perrier, E | 1 |
| Carlioz, R | 1 |
| Gouteyron, JF | 1 |
1 review available for amiodarone and Arrhythmogenic Right Ventricular Cardiomyopathy
| Article | Year |
|---|---|
[Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amiodarone; Anesthesia, General; Anesthesia, | 2014 |
18 other studies available for amiodarone and Arrhythmogenic Right Ventricular Cardiomyopathy
| Article | Year |
|---|---|
Arrhythmogenic Right Ventricular Cardiomyopathy: An Exuberant Case Affecting Both Ventricles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; | 2020 |
Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; C | 2019 |
Atrioventricular Conduction Disorder as a First Manifestation of Arrhythmogenic Right Ventricular Dysplasia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmogenic Righ | 2016 |
Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventric | 2009 |
Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dy | 2009 |
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Death, Sudden | 2011 |
Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Impl | 2011 |
The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Implantable; Echocardiograph | 2012 |
Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ve | 2002 |
Arrhythmogenic right ventricular dysplasia presenting as acute coronary syndrome: a case report.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Coron | 2004 |
[Myocarditis and arrhythmogenic dysplasia of right ventricle].
Topics: Aged; Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; Cardiac Pacing, A | 2006 |
[Arrhythmogenic right ventricular dysplasia in the elderly].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Electric Count | 2007 |
Arrhythmogenic right ventricular dysplasia:clinical study.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter | 2007 |
[Sudden death in young persons caused by arrhythmogenic right ventricular dysplasia].
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Death, S | 1998 |
Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Autoantibodie | 1998 |
[Right ventricular thrombosis in arrhythmogenic cardiomyopathy. A case report].
Topics: Acenocoumarol; Adult; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmogenic Right Ventr | 2000 |
Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventric | 2000 |
[Value of total thyroidectomy in amiodarone-induced hyperthyroidism].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Emergencies; | 2001 |